Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The New York Glaucoma Research Institute (NYGRI) is a non-profit organization dedicated to the prevention of blindness through research, education, and clinical innovation in the field of glaucoma. Founded by Dr. Robert Ritch and based at the New York Eye and Ear Infirmary of Mount Sinai, the institute focuses on understanding the underlying causes of various forms of glaucoma, including exfoliation syndrome and pigmentary glaucoma. NYGRI supports clinical trials, develops new diagnostic techniques, and provides educational resources for both medical professionals and patients. Their work spans from basic laboratory research to the implementation of advanced surgical and pharmacological treatments to improve patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New York Glaucoma Research Institute.